mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.2 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.2 |